{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:43:13Z","timestamp":1791020593554,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2009,8,5]],"date-time":"2009-08-05T00:00:00Z","timestamp":1249430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s00417-009-1101-y","type":"journal-article","created":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T05:32:40Z","timestamp":1249363960000},"page":"1409-1416","source":"Crossref","is-referenced-by-count":26,"title":["Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis"],"prefix":"10.1007","volume":"247","author":[{"given":"Mario","family":"Saravia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Ferraiolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Racca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Berra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,5]]},"reference":[{"issue":"3","key":"1101_CR1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/CMR.10.3.419","volume":"10","author":"EK Wagner","year":"1997","unstructured":"Wagner EK, Bloom DC (1997) Experimental investigation of herpes simplex virus latency. Clin Microbiol Rev 10(3):419\u2013443","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"1101_CR2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/153537020122600501","volume":"226","author":"DJ Carr","year":"2001","unstructured":"Carr DJ, Harle P, Gebhardt BM (2001) The immune response to ocular herpes simplex virus type 1 infection. Exp Biol Med (Maywood) 226(5):353\u2013366","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"1101_CR3","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.micinf.2005.03.003","volume":"7","author":"PS Biswas","year":"2005","unstructured":"Biswas PS, Rouse BT (2005) Early events in HSV keratitis-setting the stage for a blinding disease. Microbes Infect 7(4):799\u2013810","journal-title":"Microbes Infect"},{"issue":"4","key":"1101_CR4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.ico.0000183485.85636.ff","volume":"25","author":"C Cursiefen","year":"2006","unstructured":"Cursiefen C et al (2006) Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea 25(4):443\u2013447. doi: 10.1097\/01.ico.0000183485.85636.ff","journal-title":"Cornea"},{"issue":"1","key":"1101_CR5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/08820530500509358","volume":"21","author":"MR Dana","year":"2006","unstructured":"Dana MR (2006) Angiogenesis and lymphangiogenesis-implications for corneal immunity. Semin Ophthalmol 21(1):19\u201322. doi: 10.1080\/08820530500509358","journal-title":"Semin Ophthalmol"},{"issue":"5","key":"1101_CR6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s004170050251","volume":"237","author":"A Heiligenhaus","year":"1999","unstructured":"Heiligenhaus A et al (1999) CD4+ T-cell type 1 and type 2 cytokines in the HSV-1 infected cornea. Graefes Arch Clin Exp Ophthalmol 237(5):399\u2013406. doi: 10.1007\/s004170050251","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"1101_CR7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1167\/iovs.06-0053","volume":"48","author":"R Duan","year":"2007","unstructured":"Duan R et al (2007) Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK. Invest Ophthalmol Vis Sci 48(1):277\u2013284. doi: 10.1167\/iovs.06-0053","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"1101_CR8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1172\/JCI0215755","volume":"110","author":"S Lee","year":"2002","unstructured":"Lee S et al (2002) Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest 110(8):1105\u20131111","journal-title":"J Clin Invest"},{"issue":"1","key":"1101_CR9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.exer.2005.05.001","volume":"82","author":"PS Biswas","year":"2006","unstructured":"Biswas PS et al (2006) Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp Eye Res 82(1):46\u201354. doi: 10.1016\/j.exer.2005.05.001","journal-title":"Exp Eye Res"},{"issue":"4","key":"1101_CR10","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1189\/jlb.0504280","volume":"76","author":"PS Biswas","year":"2004","unstructured":"Biswas PS et al (2004) Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein. J Leukoc Biol 76(4):868\u2013875. doi: 10.1189\/jlb.0504280","journal-title":"J Leukoc Biol"},{"issue":"20","key":"1101_CR11","doi-asserted-by":"crossref","first-page":"9828","DOI":"10.1128\/JVI.75.20.9828-9835.2001","volume":"75","author":"M Zheng","year":"2001","unstructured":"Zheng M et al (2001) Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J Virol 75(20):9828\u20139835. doi: 10.1128\/JVI.75.20.9828-9835.2001","journal-title":"J Virol"},{"issue":"23","key":"1101_CR12","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","volume":"350","author":"H Hurwitz","year":"2004","unstructured":"Hurwitz H et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350(23):2335\u20132342. doi: 10.1056\/NEJMoa032691","journal-title":"N Engl J Med"},{"issue":"1","key":"1101_CR13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/IAE.0b013e31815e9313","volume":"28","author":"IU Scott","year":"2008","unstructured":"Scott IU et al (2008) Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema. Retina 28(1):36\u201340. doi: 10.1097\/IAE.0b013e31815e9313","journal-title":"Retina"},{"issue":"2","key":"1101_CR14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ajo.2007.09.031","volume":"145","author":"ZF Bashshur","year":"2008","unstructured":"Bashshur ZF et al (2008) Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study. Am J Ophthalmol 145(2):249\u2013256. doi: 10.1016\/j.ajo.2007.09.031","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"1101_CR15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/ICO.0b013e318159019f","volume":"27","author":"I Bahar","year":"2008","unstructured":"Bahar I et al (2008) Subconjunctival bevacizumab injection for corneal neovascularization. Cornea 27(2):142\u2013147. doi: 10.1097\/ICO.0b013e318159019f","journal-title":"Cornea"},{"issue":"1","key":"1101_CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/02713680701799101","volume":"33","author":"I Bahar","year":"2008","unstructured":"Bahar I et al (2008) Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium. Curr Eye Res 33(1):23\u201328. doi: 10.1080\/02713680701799101","journal-title":"Curr Eye Res"},{"key":"1101_CR17","doi-asserted-by":"crossref","unstructured":"Chen WL, et al Subconjunctival injection of bevacizumab (Avastin) inhibits corneal neovascularization in different rabbit models of corneal angiogenesis. Invest Ophthalmol Vis Sci, 2008","DOI":"10.1167\/iovs.08-1997"},{"key":"1101_CR18","first-page":"285","volume":"98","author":"PA Asbell","year":"2000","unstructured":"Asbell PA (2000) Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy. Trans Am Ophthalmol Soc 98:285\u2013303","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"2","key":"1101_CR19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1089\/oli.2005.15.72","volume":"15","author":"AK Azkur","year":"2005","unstructured":"Azkur AK et al (2005) Blocking mouse MMP-9 production in tumor cells and mouse cornea by short hairpin (sh) RNA encoding plasmids. Oligonucleotides 15(2):72\u201384. doi: 10.1089\/oli.2005.15.72","journal-title":"Oligonucleotides"},{"issue":"6","key":"1101_CR20","first-page":"1808","volume":"32","author":"BL Rong","year":"1991","unstructured":"Rong BL et al (1991) Detection of herpes simplex virus thymidine kinase and latency-associated transcript gene sequences in human herpetic corneas by polymerase chain reaction amplification. Invest Ophthalmol Vis Sci 32(6):1808\u20131815","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"1101_CR21","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.4049\/jimmunol.161.8.4289","volume":"161","author":"S Gangappa","year":"1998","unstructured":"Gangappa S et al (1998) Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition. J Immunol 161(8):4289\u20134300","journal-title":"J Immunol"},{"issue":"4","key":"1101_CR22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00003226-199807000-00011","volume":"17","author":"MR Dana","year":"1998","unstructured":"Dana MR, Zhu SN, Yamada J (1998) Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea 17(4):403\u2013409. doi: 10.1097\/00003226-199807000-00011","journal-title":"Cornea"},{"issue":"7","key":"1101_CR23","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","volume":"113","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen C et al (2004) VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113(7):1040\u20131050","journal-title":"J Clin Invest"},{"issue":"8","key":"1101_CR24","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/archopht.1989.01070020221029","volume":"107","author":"TJ Liesegang","year":"1989","unstructured":"Liesegang TJ et al (1989) Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 107(8):1155\u20131159","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"1101_CR25","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0002-9440(10)61777-4","volume":"159","author":"M Zheng","year":"2001","unstructured":"Zheng M et al (2001) Control of stromal keratitis by inhibition of neovascularization. Am J Pathol 159(3):1021\u20131029","journal-title":"Am J Pathol"},{"key":"1101_CR26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1034\/j.1600-065X.2003.00038.x","volume":"193","author":"HU Simon","year":"2003","unstructured":"Simon HU (2003) Neutrophil apoptosis pathways and their modifications in inflammation. Immunol Rev 193:101\u2013110. doi: 10.1034\/j.1600-065X.2003.00038.x","journal-title":"Immunol Rev"},{"issue":"9","key":"1101_CR27","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","volume":"91","author":"RJ D\u2019Amato","year":"1994","unstructured":"D\u2019Amato RJ et al (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91(9):4082\u20134085. doi: 10.1073\/pnas.91.9.4082","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1101_CR28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","volume":"12","author":"JH Chang","year":"2001","unstructured":"Chang JH et al (2001) Corneal neovascularization. Curr Opin Ophthalmol 12(4):242\u2013249. doi: 10.1097\/00055735-200108000-00002","journal-title":"Curr Opin Ophthalmol"},{"issue":"7","key":"1101_CR29","first-page":"1588","volume":"30","author":"WL Haynes","year":"1989","unstructured":"Haynes WL, Proia AD, Klintworth GK (1989) Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat. Invest Ophthalmol Vis Sci 30(7):1588\u20131593","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 1","key":"1101_CR30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1634\/theoncologist.9-suppl_1-43","volume":"9","author":"HS Rugo","year":"2004","unstructured":"Rugo HS (2004) Bevacizumab in the treatment of breast cancer: rationale and current data. Oncologist 9(Suppl 1):43\u201349. doi: 10.1634\/theoncologist.9-suppl_1-43","journal-title":"Oncologist"},{"key":"1101_CR31","doi-asserted-by":"crossref","unstructured":"Hurwitz H, Saini S (2006) Bevacizumab in the treatment of metastatic colorectal cancer: safety profile and management of adverse events. Semin Oncol 33(5)(Suppl 10):S26\u2013S34. doi: 10.1053\/j.seminoncol.2006.08.001","DOI":"10.1053\/j.seminoncol.2006.08.001"},{"key":"1101_CR32","first-page":"330","volume":"105","author":"R Dana","year":"2007","unstructured":"Dana R (2007) Comparison of topical interleukin-1 vs. tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 105:330\u201343","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"6","key":"1101_CR33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/QAI.0b013e31815b833a","volume":"27","author":"MA Carrasco","year":"2008","unstructured":"Carrasco MA (2008) Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis. Cornea 27(6):743\u2013745","journal-title":"Cornea"},{"issue":"9","key":"1101_CR34","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/ICO.0b013e31817786ad","volume":"27","author":"PP Doctor","year":"2008","unstructured":"Doctor PP, Bhat PV, Foster CS (2008) Subconjunctival bevacizumab for corneal neovascularization. Cornea 27(9):992\u2013995. doi: 10.1097\/ICO.0b013e31817786ad","journal-title":"Cornea"},{"key":"1101_CR35","doi-asserted-by":"crossref","unstructured":"Han YS, et al Inhibitory effects of bevacizumab on angiogenesis and corneal neovascularization. Graefes Arch Clin Exp Ophthalmol, 2008","DOI":"10.1007\/s00417-008-0976-3"},{"issue":"3","key":"1101_CR36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/ICO.0b013e318160d019","volume":"27","author":"V Hurmeric","year":"2008","unstructured":"Hurmeric V et al (2008) Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs. Cornea 27(3):357\u2013362. doi: 10.1097\/ICO.0b013e318160d019","journal-title":"Cornea"},{"issue":"3","key":"1101_CR37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/ICO.0b013e31815cf67d","volume":"27","author":"TI Kim","year":"2008","unstructured":"Kim TI et al (2008) Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin). Cornea 27(3):349\u2013352. doi: 10.1097\/ICO.0b013e31815cf67d","journal-title":"Cornea"},{"issue":"9","key":"1101_CR38","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/ICO.0b013e31817c41e3","volume":"27","author":"CX Qian","year":"2008","unstructured":"Qian CX et al (2008) Combined use of superficial keratectomy and subconjunctival bevacizumab injection for corneal neovascularization. Cornea 27(9):1090\u20131092. doi: 10.1097\/ICO.0b013e31817c41e3","journal-title":"Cornea"},{"issue":"4","key":"1101_CR39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/092739490500363","volume":"12","author":"L Remeijer","year":"2004","unstructured":"Remeijer L, Osterhaus A, Verjans G (2004) Human herpes simplex virus keratitis: the pathogenesis revisited. Ocul Immunol Inflamm 12(4):255\u2013285. doi: 10.1080\/092739490500363","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"1101_CR40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1590\/S0001-37652007000300004","volume":"79","author":"LF Barros","year":"2007","unstructured":"Barros LF, Belfort R Jr (2007) The effects of the subconjunctival injection of bevacizumab (Avastin) on angiogenesis in the rat cornea. An Acad Bras Cienc 79(3):389\u2013394. doi: 10.1590\/S0001-37652007000300004","journal-title":"An Acad Bras Cienc"},{"issue":"8","key":"1101_CR41","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/ICO.0b013e3180de1d0a","volume":"26","author":"E Yoeruek","year":"2007","unstructured":"Yoeruek E et al (2007) Safety profile of bevacizumab on cultured human corneal cells. Cornea 26(8):977\u2013982. doi: 10.1097\/ICO.0b013e3180de1d0a","journal-title":"Cornea"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-009-1101-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-009-1101-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-009-1101-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T06:34:05Z","timestamp":1685082845000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-009-1101-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,5]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["1101"],"URL":"https:\/\/doi.org\/10.1007\/s00417-009-1101-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,5]]}}}